Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
IBN Quote, Financials, Valuation and Earnings
Last price:
$30.03
Seasonality move
:
1.8%
Day range:
$29.97 - $30.14
52-week range:
$27.42 - $34.57
Dividend yield:
0.86%
P/E ratio:
17.84x
P/S ratio:
3.12x
P/B ratio:
2.84x
Volume:
2.4M
Avg. volume:
5M
1-year change:
-1.61%
Market cap:
$107.2B
Revenue:
$34.7B
EPS (TTM):
$1.68
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.8B | $21.1B | $23.2B | $28.5B | $34.7B | |
| Revenue Growth (YoY) | 2.67% | -2.93% | 9.76% | 22.95% | 21.63% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.1B | $337.3M | $142.3M | $372.3M | $524.5M | |
| Operating Expenses | -$4.1B | -$4.8B | -$6.6B | -$7.4B | -$8.8B | |
| Operating Income | $4.1B | $4.8B | $6.6B | $7.4B | $8.8B | |
| Net Interest Expenses | $161.7M | $59.1M | $166.5M | $387.9M | $493M | |
| EBT. Incl. Unusual Items | $3.5B | $4.6B | $5.8B | $7.3B | $8.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $763M | $1.1B | $1.5B | $1.9B | $2.2B | |
| Net Income to Company | $3.2B | $4.5B | $5.7B | $7.2B | $8.2B | |
| Minority Interest in Earnings | $266.7M | $191.7M | $177.3M | $220.3M | $418.7M | |
| Net Income to Common Excl Extra Items | $2.7B | $3.6B | $4.4B | $5.6B | $6.5B | |
| Basic EPS (Cont. Ops) | $0.73 | $0.97 | $1.22 | $1.53 | $1.71 | |
| Diluted EPS (Cont. Ops) | $0.72 | $0.95 | $1.19 | $1.50 | $1.68 | |
| Weighted Average Basic Share | $3.4B | $3.5B | $3.5B | $3.5B | $3.5B | |
| Weighted Average Diluted Share | $3.4B | $3.5B | $3.6B | $3.6B | $3.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $9.3B | $10.1B | $12B | $16.3B | $19.1B | |
| Revenue (Reported) | $21.8B | $21.1B | $23.2B | $28.5B | $34.7B | |
| Operating Income (Reported) | $4.1B | $4.8B | $6.6B | $7.4B | $8.8B | |
| Operating Income (Adjusted) | $9.3B | $10.1B | $12B | $16.3B | $19.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.7B | $6.9B | $8.7B | $8.7B | |
| Revenue Growth (YoY) | 0.8% | 6.22% | 22.42% | 25.65% | 0.15% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$1.1B | -$1.4B | -$1.8B | -$2.2B | -$2.2B | |
| Operating Income | $1.1B | $1.4B | $1.8B | $2.2B | $2.2B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.2B | $1.4B | $1.8B | $2.2B | $2.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $274.7M | $349.6M | $460.7M | $553.4M | $550.6M | |
| Net Income to Company | $2B | $2.6B | $3.5B | $4B | -- | |
| Minority Interest in Earnings | $64.6M | $44.4M | $55M | $114.4M | $110.1M | |
| Net Income to Common Excl Extra Items | $886.8M | $1B | $1.4B | $1.7B | $1.6B | |
| Basic EPS (Cont. Ops) | $0.24 | $0.29 | $0.38 | $0.44 | $0.43 | |
| Diluted EPS (Cont. Ops) | $0.23 | $0.28 | $0.37 | $0.43 | $0.42 | |
| Weighted Average Basic Share | $3.5B | $3.5B | $3.5B | $3.5B | $3.6B | |
| Weighted Average Diluted Share | $3.5B | $3.6B | $3.6B | $3.6B | $3.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.5B | $2.9B | $4B | $4.9B | $4.7B | |
| Revenue (Reported) | $5.3B | $5.7B | $6.9B | $8.7B | $8.7B | |
| Operating Income (Reported) | $1.1B | $1.4B | $1.8B | $2.2B | $2.2B | |
| Operating Income (Adjusted) | $2.5B | $2.9B | $4B | $4.9B | $4.7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $21.6B | $21.8B | $25.6B | $32B | $35.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -$75.3M | -- | |
| Operating Expenses | -$4B | -$5.2B | -$6.6B | -$8B | -$8.9B | |
| Operating Income | $4B | $5.2B | $6.6B | $8B | $8.9B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4B | $5.4B | $6.8B | $8.1B | $8.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $937.5M | $1.3B | $1.7B | $2B | $2.3B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $217.5M | $190.7M | $193.1M | $325.5M | $427.5M | |
| Net Income to Common Excl Extra Items | $3.1B | $4B | $5.1B | $6B | $6.6B | |
| Basic EPS (Cont. Ops) | $0.73 | $1.11 | $1.40 | $1.62 | $1.75 | |
| Diluted EPS (Cont. Ops) | $0.82 | $1.09 | $1.37 | $1.59 | $1.68 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $9.5B | $11.1B | $14.3B | $18B | $19.4B | |
| Revenue (Reported) | $21.6B | $21.8B | $25.6B | $32B | $35.5B | |
| Operating Income (Reported) | $4B | $5.2B | $6.6B | $8B | $8.9B | |
| Operating Income (Adjusted) | $9.5B | $11.1B | $14.3B | $18B | $19.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10.1B | $10.7B | $13.3B | $16.8B | $17.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$2B | -$2.7B | -$3.5B | -$4.2B | -$4.5B | |
| Operating Income | $2B | $2.7B | $3.5B | $4.2B | $4.5B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.1B | $2.7B | $3.6B | $4.2B | $4.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $498.6M | $674M | $892.8M | $1.1B | $1.1B | |
| Net Income to Company | $2B | $2.6B | $3.5B | $4B | -- | |
| Minority Interest in Earnings | $85.8M | $85M | $101M | $206.3M | $215.1M | |
| Net Income to Common Excl Extra Items | $1.6B | $2B | $2.7B | $3.2B | $3.3B | |
| Basic EPS (Cont. Ops) | $0.42 | $0.56 | $0.75 | $0.84 | $0.87 | |
| Diluted EPS (Cont. Ops) | $0.41 | $0.55 | $0.73 | $0.82 | $0.86 | |
| Weighted Average Basic Share | $6.9B | $7B | $7B | $7B | $7.1B | |
| Weighted Average Diluted Share | $7.1B | $7.1B | $7.1B | $7.2B | $7.2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.8B | $5.7B | $7.8B | $9.4B | $9.7B | |
| Revenue (Reported) | $10.1B | $10.7B | $13.3B | $16.8B | $17.4B | |
| Operating Income (Reported) | $2B | $2.7B | $3.5B | $4.2B | $4.5B | |
| Operating Income (Adjusted) | $4.8B | $5.7B | $7.8B | $9.4B | $9.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.3B | $12.4B | $10.7B | $11.2B | $13.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.5B | $1.4B | $1.8B | $2.5B | $2.8B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $46.6M | $58.8M | $109.7M | $105.9M | $125.5M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $22.4B | $25.6B | $18.4B | $22B | $27.8B | |
| Property Plant And Equipment | $1.5B | $1.4B | $1.3B | $1.6B | $1.9B | |
| Long-Term Investments | $97.6M | $264.5M | $243.9M | $181.1M | $265M | |
| Goodwill | $14.7M | $13.4M | $12.3M | $296.7M | $989M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $215.7B | $231.8B | $238.8B | $284.1B | $309.9B | |
| Accounts Payable | $338.1M | $363M | $406.7M | $467.5M | $492.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $66.2B | $84.6B | $84.6B | $96.7B | $88.6B | |
| Long-Term Debt | $22.6B | $12.5B | $11.8B | $12.8B | $27.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $192.8B | $207B | $211.9B | $251.7B | $271.4B | |
| Common Stock | $189.2M | $183.4M | $170M | $168.4M | $166.7M | |
| Other Common Equity Adj | -- | -- | -- | $12.7B | $14.4B | |
| Common Equity | $21.6B | $24B | $26.1B | $30.7B | $36.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.3B | $789.3M | $813.6M | $1.7B | $1.7B | |
| Total Equity | $22.9B | $24.8B | $26.9B | $32.4B | $38.5B | |
| Total Liabilities and Equity | $215.7B | $231.8B | $238.8B | $284.1B | $309.9B | |
| Cash and Short Terms | $24.7B | $28.2B | $19.9B | $22.8B | $27.9B | |
| Total Debt | $22.6B | $22.3B | $24.4B | $27.4B | $27.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $22B | $17B | $15.5B | $19.6B | $18.9B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $22B | $17B | $15.5B | $19.6B | $18.9B | |
| Property Plant And Equipment | $1.4B | $1.3B | $1.4B | $1.7B | $1.9B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $12.4M | $12.2M | $347.6M | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $216.1B | $225.3B | $255.9B | $300.3B | $302.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $17.2B | $22.4B | $22.8B | $26.2B | $24.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $192.6B | $200.6B | $227.1B | $265B | $262.9B | |
| Common Stock | $186.9M | $171.3M | $168.7M | $168.2M | $160.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $756.8M | $778M | $867.5M | $1.9B | $1.8B | |
| Total Equity | $23.5B | $24.8B | $28.8B | $35.3B | $39.6B | |
| Total Liabilities and Equity | $216.1B | $225.3B | $255.9B | $300.3B | $302.6B | |
| Cash and Short Terms | $22B | $17B | $15.5B | $19.6B | -- | |
| Total Debt | $17.2B | $22.4B | $22.8B | $26.2B | $24.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.2B | $4.5B | $5.7B | $7.2B | $8.2B | |
| Depreciation & Amoritzation | $198.2M | $198.6M | $204.8M | $241.1M | $318.2M | |
| Stock-Based Compensation | $1M | $35.8M | $64.5M | $84.9M | $93.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9B | $10.5B | $7B | $10.4B | $9.6B | |
| Capital Expenditures | $227.4M | $249.6M | $307.1M | $444.3M | $564.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$20.3B | -$25.6B | -$30.8B | -$37.1B | -$27.7B | |
| Dividends Paid (Ex Special Dividend) | -- | $185.9M | $432.9M | $676.2M | $832.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4B | $4.8B | $5.2B | $4.7B | $4.8B | |
| Long-Term Debt Repaid | -$7.1B | -$4.6B | -$3.4B | -$4.7B | -$4.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.1B | $20B | $17.9B | $29.8B | $24.1B | |
| Beginning Cash (CF) | $17.2B | $19.8B | $22.8B | $16.5B | $19.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.7B | $4.8B | -$5.8B | $3.1B | $6.1B | |
| Ending Cash (CF) | $19.8B | $24.6B | $17B | $19.7B | $25.3B | |
| Levered Free Cash Flow | $8.8B | $10.3B | $6.7B | $9.9B | $9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $2.6B | $3.5B | $4B | -- | |
| Depreciation & Amoritzation | $96.2M | $63.3M | $86.8M | $154M | -- | |
| Stock-Based Compensation | $17.1M | $32.6M | $43M | $48.7M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.6B | -$2.6B | $24.5M | $5.4B | -- | |
| Capital Expenditures | $114.5M | $127.9M | $228.3M | $333M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1B | -$5.2B | -$419.9M | -$5.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -$186.9M | -$436.1M | -$677.1M | -$840.5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1B | $1.9B | $1.6B | $2.6B | -- | |
| Long-Term Debt Repaid | -$2.7B | -$1.6B | -$2.4B | -$2.6B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$2.2B | $2.2B | -$503.1M | $704.3M | -- | |
| Beginning Cash (CF) | $19.8B | $23B | $16.5B | $19.4B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.2B | -$5.6B | -$898.4M | $186.8M | -- | |
| Ending Cash (CF) | $22.1B | $17.4B | $15.6B | $19.6B | -- | |
| Levered Free Cash Flow | $7.4B | -$2.8B | -$203.7M | $5.1B | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $277.7K | $17.1M | $32.6M | $43M | $48.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $125.9M | $114.5M | $127.9M | $228.3M | $333M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$186.9M | -$436.1M | -$677.1M | -$840.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $2.6B | $3.5B | $4B | -- | |
| Depreciation & Amoritzation | $96.2M | $63.3M | $86.8M | $154M | -- | |
| Stock-Based Compensation | $17.1M | $32.6M | $43M | $48.7M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.6B | -$2.6B | $24.5M | $5.4B | -- | |
| Capital Expenditures | $114.5M | $127.9M | $228.3M | $333M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1B | -$5.2B | -$419.9M | -$5.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -$186.9M | -$436.1M | -$677.1M | -$840.5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1B | $1.9B | $1.6B | $2.6B | -- | |
| Long-Term Debt Repaid | -$2.7B | -$1.6B | -$2.4B | -$2.6B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$2.2B | $2.2B | -$503.1M | $704.3M | -- | |
| Beginning Cash (CF) | $19.8B | $23B | $16.5B | $19.4B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.2B | -$5.6B | -$898.4M | $186.8M | -- | |
| Ending Cash (CF) | $22.1B | $17.4B | $15.6B | $19.6B | -- | |
| Levered Free Cash Flow | $7.4B | -$2.8B | -$203.7M | $5.1B | -- | |
Get IBN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IBN
Sector
P/E ratio
17.84x
12.24x
PEG ratio
2.92x
0.31x
P/B ratio
2.84x
1.11x
Price / LTM sales
3.12x
1.84x
Growth Metrics
IBN
Sector
Revenue growth
0.15%
5.54%
Earnings growth
-2.09%
14.85%
Revenue (5-year growth)
10.34%
8.84%
Earnings forecast
$0.36
$0.62
Profitability
IBN
Sector
Profitability FY 2024
--
--
Return on invested capital
10.38%
5.01%
Return on assets
2.18%
1.01%
Return on equity
17.47%
9.68%
Earnings Date
Last Earnings Date
Oct
18
Next Earnings Date
Jan
24
Estimated Next Earnings Date
Jan
17
Balance Sheet
IBN
Sector
Total cash
$23B
$431.4M
Short term investments
--
$211.3M
Total assets
$309.9B
$3.1B
Long term debt
$24.2B
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
56
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
